Seeking Alpha

Regenerx Biopharmaceuticals Inc. (RGN)

()

Instablog posts on RGN

  • Cash for Cardiovascular: Who Might be Next? by Michael Becker
    By Michael D. Becker, Jeffrey Martini, Ph.D., and Janet L. DallyIn January 2007, Amgen, Inc. (AMGN) obtained an option from Cytokinetics, Inc. (CYTK) to commercialize a novel small-molecule therapeutic product candidate that activates cardiac myosin with potential applications in the treatment... More »
    August 11, 2009 • AMGN, ASTM, BHRT

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.